Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain TXMD message board posts where the ticker symbol TXMD has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest TXMD SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001387131-17-005770 Size: 6 KB
2017-12-11
8-K  Documents Current report, items 7.01 and 9.01
Acc-no: 0001387131-17-005435 (34 Act)  Size: 5 MB
2017-11-13 001-00100
171196409
SC 13G/A  Documents [Amend] Statement of acquisition of beneficial ownership by individuals
Acc-no: 0000080255-17-001399 (34 Act)  Size: 26 KB
2017-11-13 005-32384
171195304
10-Q  Documents   Interactive Data Quarterly report [Sections 13 or 15(d)]
Acc-no: 0001387131-17-005313 (34 Act)  Size: 3 MB
2017-11-07 001-00100
171180512
8-K  Documents Current report, items 2.02, 7.01, and 9.01
Acc-no: 0001387131-17-005292 (34 Act)  Size: 118 KB
2017-11-06 001-00100
171178129
CERTNAS  Documents [Paper]Certification by the National Association of Securities Dealers Automated Quotation approving securities for listing
Acc-no: 9999999997-17-009197 (34 Act)  Size: 1 KB
2017-10-06 001-00100
17010634
8-A12B  Documents Registration of securities [Section 12(b)]
Acc-no: 0001387131-17-004988 (34 Act)  Size: 11 KB
2017-10-06 001-00100
171127238
25  Documents Notification of the removal from listing and registration of matured, redeemed or retired securities
Acc-no: 0001387131-17-004987 (34 Act)  Size: 7 KB
2017-10-06 001-00100
171127228
8-K  Documents Current report, items 7.01 and 9.01
Acc-no: 0001387131-17-004944 (34 Act)  Size: 5 MB
2017-10-04 001-00100
171120336
8-K  Documents Current report, items 1.01 and 9.01
Acc-no: 0001193125-17-296671 (34 Act)  Size: 157 KB
2017-09-28 001-00100
171105608
More TXMD SEC Filings


Related news from
Fri, 08 Dec 2017
13:07:58 +0000
See what the IHS Markit Score report has to say about TherapeuticsMD Inc.
Short interest is extremely high for TXMD with more than 20% of shares on loan. This means that investors who seek to profit from falling equity prices are currently targeting TXMD. Over the last month, growth of ETFs holding TXMD is favorable, with net inflows of $5.17 billion.
Fri, 01 Dec 2017
12:30:00 +0000
Recent Analysis Shows FS Investment, TherapeuticsMD, Kennedy-Wilson, Louisiana-Pacific, Vmware, and ZAGG Market Influences — Renewed Outlook, Key Drivers of Growth
NEW YORK, Dec. 01, 2017-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of FS ...
Thu, 30 Nov 2017
14:42:22 +0000
Cantor Bets TherapeuticsMD Bears Could Be Getting Desperate; Here’s Why
TherapeuticsMD Inc (NASDAQ:TXMD) has a bull cheering on back of news the drug maker is resubmitting its NDA to the FDA for vaginal softgel capsule TX-004- an asset that this Wall Street analyst votes has good chances for approval, especially if regulators are involved here. Cantor analyst William Tanner finds that as the company makes its way to garnering the FDA nod in dyspareunia, what reasons do bears have left to cling to aside from "desperation?"
Wed, 29 Nov 2017
21:30:00 +0000
TherapeuticsMD Announces Resubmission of New Drug Application for TX-004HR
TherapeuticsMD, Inc. , an innovative women’s healthcare company, announced today that it has resubmitted the New Drug Application for TX-004HR, the company’s investigational applicator-free estradiol vaginal softgel capsule for the treatment of moderate-to-severe vaginal pain during sexual intercourse , a symptom of vulvar and vaginal atrophy due to menopause, with the U.S.
Mon, 27 Nov 2017
21:09:33 +0000
ETFs with exposure to TherapeuticsMD, Inc. : November 27, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to TherapeuticsMD, Inc. Here are 5 ETFs with the largest exposure to TXMD-US. Comparing the performance and risk of TherapeuticsMD, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more <b>(Read more...)</b>
Fri, 24 Nov 2017
13:47:22 +0000
This Hedge Fund Bull Bets on Teva Pharmaceutical Industries (TEVA) and TherapeuticsMD (TXMD)
In a multi-billion dollar industry fighting for alpha, Laurion Capital’s Benjamin Smith is betting on these two healthcare stocks for success. But while giant Teva Pharmaceutical (NYSE:TEVA) is plunging following the latest bad news onslaught, soaring TherapeuticsMD (NYSE:TXMD) looks like it could just be the winning ticket.
Thu, 09 Nov 2017
12:54:55 +0000
TherapeuticsMD, Inc. breached its 50 day moving average in a Bearish Manner : TXMD-US : November 9, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for TherapeuticsMD, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more <b>(Read more...)</b>
Wed, 08 Nov 2017
16:13:25 +0000
Edited Transcript of TXMD earnings conference call or presentation 6-Nov-17 1:00pm GMT
Q3 2017 TherapeuticsMD Inc Earnings Call
Mon, 09 Oct 2017
16:07:32 +0000
ETFs with exposure to TherapeuticsMD, Inc. : October 9, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to TherapeuticsMD, Inc. Here are 5 ETFs with the largest exposure to TXMD-US. Comparing the performance and risk of TherapeuticsMD, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more <b>(Read more...)</b>
Mon, 09 Oct 2017
12:43:00 +0000
TherapeuticsMD CEO on the switch to Nasdaq from NYSE
TherapeuticsMD CEO Robert Finizio discusses his company's transfer from listing on the NYSE to listing on the Nasdaq as well as why the pharma company has been successful with women's issues.
Fri, 06 Oct 2017
14:00:00 +0000
TherapeuticsMD, Inc. (Nasdaq: TXMD) to Ring The Nasdaq Stock Market Opening Bell in Celebration of Its Listing On Nasdaq
What: TherapeuticsMD, Inc., an innovative healthcare company focused on developing and commercializing products exclusively for women, will visit the Nasdaq MarketSite in Times Square in celebration of ...
Fri, 06 Oct 2017
13:04:54 +0000
TherapeuticsMD, Inc. :TXMD-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017
Categories: Yahoo FinanceGet free summary analysis TherapeuticsMD, Inc. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 4.25 million, Net Earnings of USD -19.68 million. Gross margins widened from 73.78% to 82.71% compared to the same period last year, operating (EBITDA) margins now -465.28% from -481.17%. Change in operating cash ... Read more <b>(Read more...)</b>
Thu, 05 Oct 2017
10:45:00 +0000
TherapeuticsMD Announces Multiple Presentations Related to TX-004HR and TX-001HR at NAMS 2017
TherapeuticsMD, Inc. , an innovative women’s healthcare company, today announced the schedule of nine presentations at NAMS 2017, the annual meeting of the North American Menopause Society, in Philadelphia, Pennsylvania, October 11-14, related to TX-004HR, the company’s investigational applicator-free vaginal estradiol softgel capsule in development for the treatment of moderate-to-severe vaginal pain ...
Thu, 28 Sep 2017
20:15:00 +0000
TherapeuticsMD Announces Closing of Common Stock Offering
TherapeuticsMD, Inc. today announced the closing of its previously announced underwritten public offering of 12.4 million shares of its common stock. At closing, TherapeuticsMD received net proceeds from the offering of approximately $68.5 million, after deducting offering expenses.
Thu, 28 Sep 2017
14:30:42 +0000
TherapeuticsMD, Inc. – Value Analysis (NYSE AMERICAN:TXMD) : September 28, 2017
Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives TherapeuticsMD, Inc. a score of 25. Our analysis is based on comparing TherapeuticsMD, Inc. with the following peers – AMAG Pharmaceuticals, Inc., Lannett Company, Inc., Agile Therapeutics, Inc., Apricus Biosciences, Inc., AbbVie, Inc., Juniper Pharmaceuticals, Inc., Repros Therapeutics Inc., Pfizer Inc. and Pernix Therapeutics Holdings, Inc. (AMAG-US, ... Read more <b>(Read more...)</b>



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "ValueForum is the gold standard, valuable because of the exceptional people who post here, and because the best of them are candid, detailed and informed. There is little tolerance for the b.s. found on public boards, and management and members are vigilant and aggressive about TOS violations. VF is the gold standard." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2017, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards